nougatine1

All Eyes on Cel-Sci: Will Wednesday's Surge Continue?

My problem is now AGEN...
For the others I only can confirm my prevision...
CYTK, VVUS, GNBT, CVM, INO, NVAX, AMGN...
But share values were bashed...!!!!

Playing the Options Game in RIM; Cel Sci Not Yet Trading to Its Potential

VFC... My Pb is AGEN!!!
For CVM...look at this info...If it's right...and not manipulate...
VFC you are on the right way...
" CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine"
For me this mean...Next step will be "official" under very short time period...

TheStreet.com's Accounting Mess: What Would Jim Cramer Have to Say?

Last Cramer interview about Sanofi Aventis was nice...Because he let people speak...
www.cnbc.com/id/34065501

AF was right last week on Genzyme...and industrial catastoph...
AF was wrong about CVM...

Cramer was also right for now about VVUS...Absolutely speculative value!!!!! up and down and get the monney...

Diabetes Care: Global Investing Opportunities

And GNBT...

Cytokinetics' Market Potential

WAIT their presentation..
And I do not understand why they refuse to call about takeover...If they do not have a strong pipeline...
In all case AMGEN need blockbuster after theri last results...and will not want to invest in something not "rentable..."
Before christmas...we will have more datas...
But stay in "hold..."

Cel-Sci: Good News Could Lead to Long-Term Growth

VFC Just let one month and J.Hopkins...evolution + Flu...And will can call after...AF is quiet now...

Cel-Sci, Johns Hopkins Move Forward with LEAPS

CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response
Good Job VFC...

Cel-Sci, Johns Hopkins Move Forward with LEAPS

On Monday and Tuesday of this week, the 7th Annual Vaccines: All Things Considered Conference is taking place in Washington, DC
community.smallcapnetw.../

Four Biotech Stocks to Play the Sector Pullback

WHO experts forecast three waves of A/H1N1 flu in Ukraine
Posted on November 7, 2009 by niarane
The World Health Organization has forecasted three waves of A/H1N1 flu in Ukraine and in the world.
Yesterday at 13:39 | Interfax-Ukraine The World Health Organization (WHO) has forecasted three waves of A/H1N1 flu in Ukraine and in the world, Head of WHO office in Ukraine Ihor Pokanevych told Deutsche Welle on Nov. 5.
According to him, the first wave is being observed now, the second will come next spring, and the third during the autumn of 2010.
Pokanevych said that imposing quarantines and vaccination should be the main focus of flu A/H1N1 prevention in Ukraine. According to him, it would be reasonable to continue quarantine measures in Ukraine’s western regions and to impose quarantine in the regions where a rate of infections may soon exceed the epidemiological threshold.
Moreover, Pokanevych insisted on the need for the urgent immunization of the population against the A/H1N1 virus.

Four Biotech Stocks to Play the Sector Pullback

H1N1 flu vaccine—why the delay?
www.youtube.com/watch?...

Four Biotech Stocks to Play the Sector Pullback

VFC...Good JOB....

"CEL-SCI to Conduct First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 I."

CDC Sticking with 'Tried and True' Methods for Flu Vaccines

Hi everybody...
Question about vaccines and adjuvants is very simple...It's economical strategic and healthcare strategy...
If you take a look to Google Flu...Trends...You will understand why US and other countries with actually not too bad temperature (H1N1 development...increased by low temperature...) have better results than CANADA...UKRAINE...RUS... this time...
Analyze curbs and you will have a clear vision to US evolution...when temperature will be lower...
For CDC situation is clear...They have a Flu Pick before normal arrival...and can't do anything to get vaccines before this first pick...
Because they can't control speed flu development...
Commands passed to traditional manufacturers went at the right time for eggs process...But not in this H1N1 cases...
So with a Flu pick in normal season...it must be end of november to december....and after...
So in the time...to isolate H1N1 souch....manufacture first eggs batches...Gained Approval "planning were respected..." but problem were added within very low yield and so few vaccines conforms manufactured...With adjuvants criticals approbation with or without...and deals between for example...AGEN and others companies....
Today, situation is very clear...There is a shorteage in time for traditionals manufacturers with "old eggs" process...
So question is about NVAX, INOVIO, CVM...an others...They are only abble to ramp up very quickly manufacturing....with for example NVAX one process already performs by NVS or BAXTER or AZN...but not by SP, GSK...on VLP, cell process or LEAPS...
It's why also...CVM and Biocryst have a very strong potential market for their products...Few vaccines egual more sicks...and more sicks egual more product potential use for CVM and BIOCRYST....
cqfd...
It's why also INOVIO renforce his team...with senior from vaccines for a better speed to the market....
After it's a safety, regulatory..;and political decision to develop small biotech in this situation...
One complementary advice...cell culture process...is better paid by government....take a look to prices contracts....for Baxter by example..;and GSK you will see a difference...
So for these reasons before the end of this year...AGEN, NVAX, INOVIO, CVM, Biocryst...have a bigger share value potential development...than major installed companies with higher share value...Jump will be more important...

Four Biotech Stocks to Play the Sector Pullback

Hi VFC...
AGEN: Develop critical vaccines fuel...Adjuvants...2 possibilities...Self development...Long Time...But depend Flu spread...or TakeOver...I don't see GSK accept to share his technology with a lot of others...
My intime conviction at this share price..TakeOver...See the last transcript from AGEN...Adjuvants are the keys...

CVM...like NVAX...and Inovio...Strongly Depend of Flu spead development...
CVM...New Tech and potential abiity to ramp up...who can interest a Big Giant....Wait future development...One thing is sure..;and it's for all over small biotech capital...They need monney to finalize their clinical phase...And it's why they need 10 millions $...Logical...

NVAX...Take a look to their strategy...Development within an American company...GE and outside US contracts...In first time...on emergent markets...Their technology is not new...used for example by AZN...Take a look to their price for one dose...Higher than SP or GSK or NVS...Because New Tech...This development for NVAX or others will depend of US political strategy on new tech....
Inovio...Take a look to their last Board recrutment...Big profile from SP...Need garantee...credility...In line with last CDC requirements on tech equivalence...between Eggs and new tech...From my point of view...I do not see this kind of profile to go in small Biotech with their great background...To play domino's....Same feeling than GNBT...

GNBT...Few product and potential for takeover...
My question for this company is ...Why one of the AMGEN's 3-4 foundators went to work with this company (Medical Board position...) to play also domino's...I understand new challenge...new spirit and capacities to create something new...But...
For this company...You have to retrace their last decisions since this arrival...And to understand...why they won't sell shares...before end of this year and want to stay in Nasdaq...Except "Takeover"...and analyze also their product and AMGEN's porfolio for GNBT products...Diabets...m... is the question...
From my pointof view...This copany is well managed...And better managed since this arrival...

Will see who will be right...

Biotech Sector Pullback: Good Time to Buy at a Discount

"In today's age - the age of true greed - the small investor has to be more confident than ever in their own Due Diligence (DD) to survive the volatility and the manipulation. "

Fully agree VFC...like Obesity drugs...
Question is irrationality for us...But very clear for them...Down maxi the share and jump ASAP for taking the money...with maxi shares...
AGEN...after earnings..."Rebound today...?"
One advice...: Choose your DD and stay on...because shares are manipulated...Look at obesity drugs...You will constat a very interesting evidence between CEO interview and share evolution...during CNBC's sqwake box..."Hilarous..."

Antigenics Should Rise on the Promise of Cancer Immunotherapy Treatments

For Takeover...Yes...CRITICAL Tech on solvants...
For VVUS...It was Cramer...who thought as speculative....